Medicare Guidance: Payment for AI-Enabled Remote Monitoring Devices.
This Act requires the Secretary of Health and Human Services to issue guidance by January 1, 2027, on Medicare Part B payment requirements for remote monitoring devices, such as continuous glucose monitors, that utilize artificial intelligence. The goal is to clarify coverage for innovative medical technologies that automatically adjust treatment and transmit data to healthcare providers. Citizens relying on Medicare can expect clearer rules for the reimbursement of these advanced medical devices.
Key points
Mandates clear Medicare Part B payment guidance for remote monitoring devices (e.g., glucose monitors) that incorporate artificial intelligence components.
Guidance must be issued by January 1, 2027, aiming to ensure timely patient access to modern medical technology.
Applies to devices that use AI for continuous adjustment and transmit information to a healthcare provider for treatment management.
Introduced
Citizen Poll